Sonnet BioTherapeutics logo

Sonnet BioTherapeutics

0 followers

SONN

Performance

About Sonnet BioTherapeutics

Sonnet BioTherapeutics is a biotechnology company developing targeted immuno-oncology drugs using its proprietary FHAB technology to empower innovative targeted biologic drugs.

Recent News

HYPE Jumps 8% After $888 Million DAT Gets Approved

Recent Deals

Sonnet BioTherapeutics Merges with Rorschach LLC to Form First HYPE Treasury Company

December 2, 2025

Sonnet BioTherapeutics Merges with Rorschach LLC to Form First HYPE Treasury Company

December 2, 2025